secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardion Health Sciences, Inc. (—)
CIK:        0001642375
Form:       8-K
Filed at:   2024-10-03T23:59:59+00:00
Accession:  0001493152-24-039292
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 3.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Guardion Health Sciences to delist from Nasdaq, dissolve, and liquidate with ~$3.25/share distribution
--------------------------------------------------------------------------------

- Voluntary delisting from Nasdaq effective Oct 21; trading suspended Oct 14; Form 25 filed ~Oct 11.
- Certificate of dissolution filed Oct 22; stock transfer books close; no further stock transfers except by will.
- Anticipated liquidating dividend of ~$3.25 per share; no assurance on timing or final amount; reserves possible additional distribution.
- Mark Goldstone appointed Interim President and CEO effective Oct 18; compensation $7,500/month; replaces Janet Hall.
- Company intends to suspend SEC reporting obligations via no-action relief.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642375/000149315224039292/0001493152-24-039292-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642375/000149315224039292/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-039292

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer